← feed

Is NCT03373409 results overdue?

Yes — results are overdue. Primary completion was 2018-05-28; the FDAAA-801 reporting deadline (2019-05-28) passed 2627 days ago and no results are posted on ClinicalTrials.gov.

Safety and Pharmacokinetics of Halix(TM) Albuterol Unit Dose Disposable Inhaler Versus Albuterol MDI

NCT IDNCT03373409 ↗
SponsorConcentrx Pharmaceuticals, Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-05-28 (ACTUAL)
Reporting deadline2019-05-28 (completion + 365d)
Days overdue2627
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 c494ae3c95b13a5a… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03373409. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →